Which hedge funds own PRCT? PROCEPT BIOROBOTICS CORP, Q2 2026 13F holders
31 tracked hedge funds disclosed a position in PRCT (PROCEPT BIOROBOTICS CORP) in their Q2 2026 13F filings, worth $121.8m in total. The largest holder by portfolio weight is FirstWave Capital Management LLC at 1.4% of its book. 9 opened a new position this quarter: EntryPoint Capital, LLC, Dark Forest Capital Management LP, ExodusPoint Capital Management, LP, Centiva Capital, LP. 8 exited: Eagle Health Investments LP, Militia Capital Management LLC, Quantbot Technologies LP.
- 31
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 9
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 8
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $4.8m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $46.5m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $122m
- Combined value Sum of the holders' reported positions in the security.
- 2.5%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Eagle Health Investments LP | 2.5% | $12.1m |
| Militia Capital Management LLC | 0.2% | $863k |
| Quantbot Technologies LP | 0.08% | $2.0m |
| Point72 Asset Management, L.P. | 0.05% | $28.2m |
| Atom Investors LP | 0.03% | $395k |
| Renaissance Technologies LLC | 0.0% | $2.9m |
| IQ EQ FUND MANAGEMENT (SINGAPORE) PRIVATE Ltd | 0.0% | $2.5k |
| Quarry LP | 0.0% | $1.3k |
Ownership over time
Who discovered PRCT first? Beta
| Summit Partners Public Asset Management, LLC | Q1 2024 | +0.8 pts |
| Numerai GP LLC | Q1 2024 | +0.7 pts |
| Duquesne Family Office LLC | Q4 2021 | +0.2 pts |
| Perceptive Advisors LLC | Q3 2021 | +0.2 pts |
| Parkman Healthcare Partners LLC | Q2 2022 | −0.1 pts |
| Atika Capital Management LLC | Q4 2022 | −0.1 pts |
| Affinity Asset Advisors, LLC | Q3 2021 | −0.4 pts |
| Eagle Health Investments LP | Q3 2023 | −0.7 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.